When designing the synthesis of glycoconjugate derivatives of MTX, the following assumptions were made: glycoconjugate is selectively transferred to the cancer cell by GLUT proteins responsible for the transfer of d-glucose to tumor cells. The gene discussed is SLC2A1; the disease is cancer.